Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.
CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro.
Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors.
Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
Absence of genetic diversity reduction in the HIV-1 integrated proviral LTR sequence population during successful combination therapy.
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.
Stromal-cell-derived factor 1 prevents the emergence of the syncytium-inducing phenotype of HIV-1 in vivo.
[Resistance to protease inhibitors].
[GESIDA Consensus document on the use of resistance studies in clinical practice].